Pfizer Inc.

Stocks

Market Closed - NYSE 23:01:33 31/08/2026 +03			After hours 03:00:00
28.46 ^USD	+1.79%		28.61	+0.53%

09:40am	GSK Moves mRNA Flu Vaccine Candidate to Late-Stage Trial	DJ
09-01	Trump announces new round of drug-pricing deals	RE

Published on 06/17/2026 at 10:37 pm +03

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good day everyone and welcome to Pfizer Flash Live from ADA, spotlighting berobenatide, an investigational potential first-in-class monthly GLP-1

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

09:40am	GSK Moves mRNA Flu Vaccine Candidate to Late-Stage Trial	DJ
09-01	Trump announces new round of drug-pricing deals	RE
08-31	Donald Trump prepares new agreements to reduce drug prices
08-31	Trump administration to announce drug pricing deals	RE
08-28	BioNTech Terminates Phase 2 Colorectal Cancer Clinical Trial; Shares Fall	MT
08-28	FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax -- Update	DJ
08-28	Global markets live: Nvidia, Marvell, Rivian, Eli Lilly, Moderna…
08-28	Roivant, Priovant launch newly approved rare disease drug Lisraya at $35,000 a month	RE
08-28	Warsh Takes the Stage
08-28	A tale of two markets
08-28	FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech	DJ
08-28	Pfizer, BioNTech Get US FDA Clearance for COVID-19 Vaccine Targeting XFG Variant	MT
08-27	Pfizer And BioNTech Receive U.S. FDA Approval For XFG-Adapted COVID-19 Vaccine	CI
08-27	US FDA approves Roivant-Priovant's skin and muscle disease drug	RE
08-27	Novo Nordisk Reports China Regulators Accept Weight-Loss Drug Application	MT